Literature DB >> 30067412

CRX-linked macular dystrophy with intrafamilial variable expressivity.

Khaled Romdhane1, Veronika Vaclavik1, Daniel F Schorderet1,2,3, Francis L Munier1, H Viet Tran1.   

Abstract

BACKGROUND: We present a macular dystrophy of differing severity in a single kindred caused by a heterozygous nonsense mutation in CRX. CASE REPORT: A 21-year-old Caucasian male from a Swiss family was investigated for decreasing central visual acuity associated with dischromatopsia. Clinical examination revealed posterior pole atrophy, including the maculopapillary bundle. Multimodal imaging, including autofluorescence, showed a hyperautofluorescent paramacular ring in both eyes. Genetic analysis identified a c.313C>T, p.Q105* nonsense mutation in CRX. The same mutation was identified in his father and uncle. Both of them showed signs of the disease, however with different severity.
CONCLUSION: We describe an intrafamilial variable expressivity of a CRX mutation causing an isolated macular dystrophy.

Entities:  

Keywords:  CRX; macular dystrophy; mutation; variable expressivity

Mesh:

Substances:

Year:  2018        PMID: 30067412     DOI: 10.1080/13816810.2018.1502789

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  2 in total

1.  Targeted next generation sequencing and family survey enable correct genetic diagnosis in CRX associated macular dystrophy - a case report.

Authors:  Saoud Al-Khuzaei; Karl A Z Hudspith; Suzanne Broadgate; Morag E Shanks; Penny Clouston; Andrea H Németh; Stephanie Halford; Susan M Downes
Journal:  BMC Ophthalmol       Date:  2021-04-09       Impact factor: 2.209

2.  Genetic characteristics of 234 Italian patients with macular and cone/cone-rod dystrophy.

Authors:  Benedetto Falsini; Giorgio Placidi; Elisa De Siena; Pietro Chiurazzi; Angelo Maria Minnella; Maria Cristina Savastano; Lucia Ziccardi; Vincenzo Parisi; Giancarlo Iarossi; Marcella Percio; Barbora Piteková; Giuseppe Marceddu; Paolo Enrico Maltese; Matteo Bertelli
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.